Use RS ratings to sort out some names with high fundamentals š
$Warrior Met Coal (HCC.US)$ The RS line (main image is blue) is required to break through the previous height (the gap is not small at present)
$Oscar Health (OSCR.US)$The price needs to be further compressed to reduce the risk ratio
$Constellation Energy (CEG.US)$The graphics are all very good so far
$Applovin (APP.US)$ Tighter prices are needed, and RS and prices must be synchronized when breaking through
$Micron Technology (MU.US)$ Currently, the graphics are less than half complete, and they still need to be cleaned up.
$NVIDIA (NVDA.US)$ Since March 8, excluding small distribution days, there are currently 5 large-scale distribution days. The fundamentals are almost unbeatable, but it will take a long time to sort out.
$Viking Therapeutics (VKTX.US)$ We need to see a closer graph. Currently, RS is ahead of the price (good phenomenon), and it is not too difficult to find a low risk (stop loss within range) entry point, so it's worth waiting for the opportunity to try it out.
$Dell Technologies (DELL.US)$ The RS line is currently all good and requires tighter graphics.
$Vertiv Holdings (VRT.US)$ The risk of financial reporting has been overcome. The RS line is far ahead. It will take some time to digest the excessive extension of 50MA, quiet and other low-risk entry opportunities.
$CAVA Group (CAVA.US)$ Extremely strong fundamentals and industry ratings. Currently, the problem is still an extension of the relative moving average. RS is currently far ahead, waiting for a low-risk entry opportunity after price repair.
$Sweetgreen (SG.US)$ Basically, it lost to CAVA. Currently, there are two major distribution days, and it will take longer to fix the price and RS at the same time.
$Super Micro Computer (SMCI.US)$ Since mid-February, with the exception of the small distribution days, there are still 5 major distribution days. Although the fundamentals are almost invincible, it will take a long time to fix the price and RS, so there is no rush to enter.
$Janux Therapeutics (JANX.US)$ Other than huge revenue, other fundamental data have yet to be reflected. The 35.4% management holding ratio has good guidance, strong RS, and price trends. The difficulty of such names lies in choosing a low-risk entry point, and it is very worth trying.
$Pegasystems (PEGA.US)$ Very strong fundamentals. 50.2% of management holdings are also quite attractive. The chart is currently halfway through the compilation cycle. The recent low point has seen signs of huge fund-raising. Waiting for low-risk entry opportunities, it is necessary that there is no negative divergence between price and RS.
I recently found a way to check the 52-week RS rating and some key fundamental information in the IBD app, which helped me a lot. First, it helped me filter out a large number of players with an RS rating of less than 70, which would greatly increase the win rate for future transactions (win rate so far this year: 33% š¤).
āI've found that as long as you can do something others can't, you have an advantage. In sports and other activities, the advantage is clearly bigger, faster, stronger, etc. In the marketplace, process and patience are often the intangible factors that provide real advantage.ā -Mark Ritchie II
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
